<record xmlns="http://www.loc.gov/MARC21/slim">
   <leader>02454nam a2200397 i 4500</leader>
   <controlfield tag="001">6786195</controlfield>
   <controlfield tag="003">FlBoTFG</controlfield>
   <controlfield tag="005">20150115163112.0</controlfield>
   <controlfield tag="006">m|||||o||d||||||||</controlfield>
   <controlfield tag="007">cr||||</controlfield>
   <controlfield tag="008">150115t20152015fluad   ob    001 0 eng d</controlfield>
   <datafield ind1=" " ind2=" " tag="020">
      <subfield code="a">9781466561502 (e-book : PDF)</subfield>
   </datafield>
   <datafield ind1=" " ind2=" " tag="035">
      <subfield code="a">ocn895661613</subfield>
   </datafield>
   <datafield ind1=" " ind2=" " tag="039">
      <subfield code="a">exclude</subfield>
   </datafield>
   <datafield ind1=" " ind2=" " tag="040">
      <subfield code="a">FlBoTFG</subfield>
      <subfield code="b">eng</subfield>
      <subfield code="e">rda</subfield>
      <subfield code="c">FlBoTFG</subfield>
      <subfield code="d">AEU</subfield>
   </datafield>
   <datafield ind1=" " ind2="4" tag="050">
      <subfield code="a">R853.C55</subfield>
      <subfield code="b">N48 2015</subfield>
   </datafield>
   <datafield ind1=" " ind2=" " tag="090">
      <subfield code="a">Internet Access</subfield>
      <subfield code="b">AEU</subfield>
   </datafield>
   <datafield ind1="1" ind2=" " tag="100">
      <subfield code="a">Ng, Tie-Hua,</subfield>
      <subfield code="e">author.</subfield>
   </datafield>
   <datafield ind1="1" ind2="0" tag="245">
      <subfield code="a">Noninferiority testing in clinical trials :</subfield>
      <subfield code="b">issues and challenges /</subfield>
      <subfield code="c">Tie-Hua Ng.</subfield>
   </datafield>
   <datafield ind1=" " ind2="1" tag="264">
      <subfield code="a">Boca Raton :</subfield>
      <subfield code="b">CRC Press,</subfield>
      <subfield code="c">[2015]</subfield>
   </datafield>
   <datafield ind1=" " ind2="4" tag="264">
      <subfield code="c">Â©2015</subfield>
   </datafield>
   <datafield ind1=" " ind2=" " tag="300">
      <subfield code="a">1 online resource.</subfield>
   </datafield>
   <datafield ind1=" " ind2=" " tag="336">
      <subfield code="a">text</subfield>
      <subfield code="2">rdacontent</subfield>
   </datafield>
   <datafield ind1=" " ind2=" " tag="337">
      <subfield code="a">computer</subfield>
      <subfield code="2">rdamedia</subfield>
   </datafield>
   <datafield ind1=" " ind2=" " tag="338">
      <subfield code="a">online resource</subfield>
      <subfield code="2">rdacarrier</subfield>
   </datafield>
   <datafield ind1="1" ind2=" " tag="490">
      <subfield code="a">Chapman &amp; Hall/CRC biostatistics series</subfield>
   </datafield>
   <datafield ind1=" " ind2=" " tag="504">
      <subfield code="a">Includes bibliographical references and index.</subfield>
   </datafield>
   <datafield ind1="0" ind2=" " tag="505">
      <subfield code="a">Introduction -- Choice of noninferiority margin for the mean difference -- Choice of noninferiority margin for the mean ratio and hazard ratio -- Noninferiority Hypotheses with Binary Endpoints -- Two statistical approaches for testing the noninferiority hypothesis -- Switching between superiority and noninferiority -- Multiple historical studies and meta-analysis -- Three treatment groups -- Regulatory guidances -- Intention-to-treat versus per-protocol -- Thrombolytic example -- Issues and challenges.</subfield>
   </datafield>
   <datafield ind1=" " ind2=" " tag="506">
      <subfield code="a">Access restricted to authorized users and institutions.</subfield>
   </datafield>
   <datafield ind1=" " ind2=" " tag="520">
      <subfield code="a">"This book focuses on the rationale of choosing the noninferiority (NI) margin as a small fraction of the therapeutic effect of the active control in a clinical trial. It discusses issues of estimating the effect size based on historical placebo control trials of the active control. The book also covers basic concepts related to NI trials, such as essay sensitivity, constancy assumption, discounting, and preservation. Other topics described include patient populations, three-arm trials, and testing equivalence of three or more groups"--Provided by publisher.</subfield>
   </datafield>
   <datafield ind1=" " ind2=" " tag="596">
      <subfield code="a">44</subfield>
   </datafield>
   <datafield ind1=" " ind2="0" tag="650">
      <subfield code="a">Clinical trials.</subfield>
   </datafield>
   <datafield ind1=" " ind2="0" tag="830">
      <subfield code="a">Chapman &amp; Hall/CRC biostatistics series (Unnumbered)</subfield>
   </datafield>
   <datafield ind1="4" ind2="0" tag="856">
      <subfield code="3">University of Alberta Access</subfield>
      <subfield code="u">http://marc.crcnetbase.com/isbn/9781466561502</subfield>
      <subfield code="z">(Unlimited Concurrent Users)</subfield>
   </datafield>
   <datafield ind1=" " ind2=" " tag="949">
      <subfield code="h">UAIN</subfield>
      <subfield code="z">CRC</subfield>
   </datafield>
   <datafield ind1=" " ind2=" " tag="926">
      <subfield code="a">Internet Access</subfield>
      <subfield code="w">LC</subfield>
      <subfield code="c">1</subfield>
      <subfield code="i">6786195-1001</subfield>
      <subfield code="l">INTERNET</subfield>
      <subfield code="m">UAINTERNET</subfield>
      <subfield code="r">Y</subfield>
      <subfield code="s">Y</subfield>
      <subfield code="t">E-RESOURCE</subfield>
      <subfield code="u">1/20/2015</subfield>
      <subfield code="x">E-BOOK</subfield>
      <subfield code="z">CRC</subfield>
   </datafield>
</record>
